Postmenopausal Period Completed Phase Trials for Drospirenone (DB01395)

IndicationStatusPhase
DBCOND0046410 (Postmenopausal Period)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01064453Angeliq Regulatory Post Marketing Surveillance